Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$SOPH ($SOPH) Releases Q1 2026 Earnings

None

$SOPH ($SOPH) posted quarterly earnings results for Q1 2026 on Tuesday, May 5th. The company reported earnings of -$0.27 per share, missing estimates of -$0.24 by $0.03. The company also reported revenue of $21,690,000, beating estimates of $20,808,000 by $882,000.

You can see Quiver Quantitative's $SOPH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive SOPH Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$SOPH Insider Trading Activity

SOPH Insider Trades

$SOPH insiders have traded $SOPH stock on the open market 65 times in the past 6 months. Of those trades, 0 have been purchases and 65 have been sales.

Here’s a breakdown of recent trading of $SOPH stock by insiders over the last 6 months:

  • JURGI CAMBLONG (Chief Executive Officer) has made 0 purchases and 11 sales selling 96,055 shares for an estimated $472,229.
  • PHILIPPE MENU (Chief Medical Officer) has made 0 purchases and 11 sales selling 25,772 shares for an estimated $123,968.
  • ROSS MUKEN (President) has made 0 purchases and 9 sales selling 22,632 shares for an estimated $109,089.
  • ZHENYU XU (Chief Scientific Officer) has made 0 purchases and 10 sales selling 19,772 shares for an estimated $94,930.
  • WELL DAAN VAN (Chief Legal Officer) has made 0 purchases and 7 sales selling 13,722 shares for an estimated $66,133.
  • MANUELA VALENTE (Chief People Officer) has made 0 purchases and 5 sales selling 9,557 shares for an estimated $46,487.
  • GEORGE CARDOZA (Chief Financial Officer) has made 0 purchases and 4 sales selling 7,110 shares for an estimated $34,484.
  • ABHIMANYU VERMA (Chief Technology Officer) has made 0 purchases and 2 sales selling 3,549 shares for an estimated $17,256.
  • KEVIN PUYLAERT (Chief Sales Officer) has made 0 purchases and 6 sales selling 693 shares for an estimated $3,370.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$SOPH Hedge Fund Activity

We have seen 26 institutional investors add shares of $SOPH stock to their portfolio, and 16 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$SOPH Analyst Ratings

Wall Street analysts have issued reports on $SOPH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 11/10/2025

To track analyst ratings and price targets for $SOPH, check out Quiver Quantitative's $SOPH forecast page.

$SOPH Price Targets

Multiple analysts have issued price targets for $SOPH recently. We have seen 2 analysts offer price targets for $SOPH in the last 6 months, with a median target of $7.5.

Here are some recent targets:

  • Mark Massaro from BTIG set a target price of $8.0 on 04/15/2026
  • Subbu Nambi from Guggenheim set a target price of $7.0 on 01/26/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles